Skip to Main Content

Paper Details

Receptor-binding domain of MERS-CoV with optimal immunogen dosage and immunization interval protects human transgenic mice from MERS-CoV infection.
Hum Vaccin Immunother
45
2017
Author NameAffiliation
Chien-Te K Tsengd Department of Microbiology and Immunology and Center for Biodefense and Emerging Disease , University of Texas Medical Branch
  • 1 - 1

Datasets

Release 1.2